266 related articles for article (PubMed ID: 12632553)
1. Diabetes medicine update. Old dogs, new tricks.
Nakamoto M
Diabetes Self Manag; 2003; 20(1):14-5. PubMed ID: 12632553
[No Abstract] [Full Text] [Related]
2. Troglitazone for non-insulin-dependent diabetes mellitus.
Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
[No Abstract] [Full Text] [Related]
3. New labeling and use changes for Rezulin.
Klonoff DC
Diabetes Technol Ther; 1999; 1(3):350. PubMed ID: 11484719
[No Abstract] [Full Text] [Related]
4. Combination therapy in type 2 diabetes: the role of repaglinide.
Moses R
J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
[No Abstract] [Full Text] [Related]
5. Diabetes drug Rezulin: take it, but take precautions.
Health News; 1999 May; 5(6):7. PubMed ID: 10546576
[No Abstract] [Full Text] [Related]
6. Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.
Kohlroser J; Mathai J; Reichheld J; Banner BF; Bonkovsky HL
Am J Gastroenterol; 2000 Jan; 95(1):272-6. PubMed ID: 10638596
[TBL] [Abstract][Full Text] [Related]
7. Warner-Lambert voluntarily withdraws Rezulin.
Diabetes Technol Ther; 2000; 2(2):290. PubMed ID: 11469273
[No Abstract] [Full Text] [Related]
8. Metaglip and Avandamet for type 2 diabetes.
Med Lett Drugs Ther; 2002 Dec; 44(1146):107-9. PubMed ID: 12500153
[No Abstract] [Full Text] [Related]
9. Update in endocrinology.
Whitcomb RW
Ann Intern Med; 1998 May; 128(10):871. PubMed ID: 9599203
[No Abstract] [Full Text] [Related]
10. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.
Gorman C
Time; 2000 Apr; 155(13):94. PubMed ID: 11009709
[No Abstract] [Full Text] [Related]
11. Patients with both diabetes and heart failure often treated with medications government considers unsafe.
Levenson D
Rep Med Guidel Outcomes Res; 2003 Aug; 14(15):1, 6-7. PubMed ID: 12964577
[No Abstract] [Full Text] [Related]
12. Advisory panel hears contradictory evidence, backs keeping troglitazone on market.
Miller JL
Am J Health Syst Pharm; 1999 May; 56(9):840, 842. PubMed ID: 10344603
[No Abstract] [Full Text] [Related]
13. [Are PPAR-gamma-agonists a secure choice in treatment of overweight diabetic patients?].
Larsen PJ
Ugeskr Laeger; 2000 Aug; 162(32):4280-1. PubMed ID: 10962950
[No Abstract] [Full Text] [Related]
14. How should patients taking the discontinued diabetes drug troglitazone be managed?
Reddy SS
Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221
[No Abstract] [Full Text] [Related]
15. Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.
Diabetes Technol Ther; 2000; 2(2):292. PubMed ID: 11469275
[No Abstract] [Full Text] [Related]
16. Drug recalls underscore safety concerns.
Greene HL
Health News; 2000 May; 6(5):4. PubMed ID: 10851966
[No Abstract] [Full Text] [Related]
17. Pioglitazone-associated fulminant hepatic failure.
Chase MP; Yarze JC
Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
[No Abstract] [Full Text] [Related]
18. Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.
Diabetes Technol Ther; 2000; 2(2):290-1. PubMed ID: 11469274
[No Abstract] [Full Text] [Related]
19. Glitazones and NIDDM.
Sakane N; Yoshida T; Kondo M
Lancet; 1997 Mar; 349(9056):952. PubMed ID: 9093269
[No Abstract] [Full Text] [Related]
20. [Insulin-sensitizing agent].
Yamanouchi T
Nihon Rinsho; 1999 Mar; 57(3):675-80. PubMed ID: 10199153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]